S.MURALIDHAR
Sun Pharmaceuticals Industries – Appellant
Versus
P. Mukesh Kumar – Respondent
1. This suit has been filed Sun Pharmaceuticals Industries Limited (‘SPIL’) against Mr. P. Mukesh Kumar, the proprietor of M/s. Idalis (a division of Marx Remedies) (Defendant No.1), M/s. Marx Remedies (Defendant No.2), Invision Medi Sciences Pvt. Ltd. (Defendant No.3), M/s. Chimak Health Care located at Solan in Himachal Pradesh (Defendant No.4) and M/s. Visions located at New Delhi (Defendant No.5) for a permanent injunction restraining the Defendants from infringing the Plaintiff’s trade mark AMLOBET, passing off, rendition of accounts and delivery of the infringing goods of the Defendants etc.
2. The case of the Plaintiff is that it coined the mark AMLOBET from the salt Amlodipine and Atenolol used in treatment of high blood pressure and prevention of chest pain. Exhibit PW 1/4 is a photograph of the Plaintiff’s medicine being sold and marked as AMLOBET. On 14th October 1996 the Plaintiff obtained a drug licence to manufacture medicines under the aforementioned mark. It has been extensively and commercially used since then. Exhibit PWs 1/6, 1/7 and 1/8 are invoices of the Plaintiff for the years 1998 to 2011 which show sales of AMLOBET. The certificate from the Charte
Rakesh Kumar and Ors. v. State 183 (2009) DLT 658
Cadila Health Care Ltd. v. Cadila Pharmaceuticals Ltd. AIR 2001 SC 1952
United Biotech Pvt. Ltd. v. Orchid Chemicals 182 (2011) DLT 20
Durga Dutt v. Navaratna Pharmaceuticals AIR 1965 SC 980
Corn Products Refining Co. v. Shangrila Food Products Ltd. AIR 1960 SC 142.
Login now and unlock free premium legal research
Login to SupremeToday AI and access free legal analysis, AI highlights, and smart tools.
Login
now!
India’s Legal research and Law Firm App, Download now!
Copyright © 2023 Vikas Info Solution Pvt Ltd. All Rights Reserved.